Clinical trial
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac…
NCT00492960 · 9 Meters Biopharma, Inc., Industry · Completed
Key facts
| NCT number | NCT00492960 |
|---|---|
| Title | Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease |
| Official title | A Phase IIb, Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of Larazotide Acetate (AT-1001) in Celiac Disease Subjects During a Gluten Challenge |
| Lead sponsor | 9 Meters Biopharma, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Celiac Disease |
| Intervention type | Dietary Supplement, Drug |
| Interventions | larazotide acetate, placebo, 900 mg gluten |
| Enrollment | 171 |
| Start date | Aug 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Jun 27, 2007 |
| Last update posted | Sep 20, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: